Norma Instruments Receives Millennium Innovation Prize

Norma Instruments Receives Millennium Innovation Prize

Norma Instruments Receives Millennium Innovation Prize

The prestigious prize recognizes the innovation capabilities of Norma’s R&D team and the resulting revolutionary innovations that will benefit patients and laboratory diagnostics globally.

Norma Instruments, capital investment of DBH Group is an innovative technology company developing novel proprietary trend setting products in the field of hematology. The prestigious Millennium Innovation Prize was established by the Hungarian Intellectual Property Office (HIPO) and is awarded annually to companies who are considered technology leaders and developing innovations of significant societal impact.

Millennium Innovation Prize

Millennium Innovation Prize Honorees 2016

Tamás Ladoméry, CEO of Norma Instruments accepted the prize, here seen on the extreme right of this picture taken at the ceremony on April 26, 2016, on the World Intellectual Property Day.

The Millennium Innovation Prize is dedicated each year to the protection of the activities and the achievements by technical creators who excel in contributing to social development and progress at a worldwide scale.

Since its establishment, Norma has been focusing its research and development on creating economical, clean, environment-conscious solutions in the area of in-vitro diagnostics, especially hematology, to the benefit of the overall healthcare system.

Millennium Innovation Prize

Dr. László Ürge, Board member at Norma Instruments and at DBH Investment said: “As a result of its focused R&D Norma has introduced new techniques and filed several patents around its technological advances. It is an honour that the Hungarian Intellectual Property Office recognized these efforts and achievements with this prestigious prize. This suggests that the results are regarded not only by the healthcare market and the investment community, but also by other key members of the entire innovation value chain.”

Dr. Miklós Bendzsel, President of the Hungarian Intellectual Property Office added: “Norma is an outstanding candidate for this year’s Millennium Prize. Their development team provided unique innovations that, I am sure, will be recognized by the healthcare market soon. The company has a conscious intellectual property strategy and protects its novel innovations in an extraordinary and exemplary manner. We are proud that we can work with such young and innovative design teams.”

Looking for another success story of DBH Investment?
Ürge László